PIPages
Labs

Luther Bartelt

University of North Carolina at Chapel Hill, NC·Microbiology & Immunology

Giardia lamblia, a single-celled intestinal parasite, causes more than 300 million infections a year and is strongly linked to children growing poorly and, in some studies, to delayed cognitive development. The puzzle is that most of these infections cause no diarrhea at all, and many children never clear the parasite, yet they still suffer lasting harm.

Fields

Microbiology & Immunology

Medicine & Clinical Research

Public Health & Epidemiology

Topics

Giardia lamblia

giardiasis

intestinal parasite

Grants
2 known grants, through Apr 2031

What they work on

  1. Test whether purified recombinant Giardia proteases, protein-cutting enzymes secreted by intestinal trophozoites, damage the gut barrier using intestinal epithelial cell monolayers and primary mouse-derived intestinal cells, and whether anti-secretome antibodies block that damage.
  2. Determine whether immunization with Giardia secretome proteins before infection protects against growth impairment in gnotobiotic and conventional mouse models of childhood undernutrition, and whether antibody therapy alone prevents severe weight loss in immunodeficient mice.
  3. Expand a multi-antigen Giardia serology panel and apply it to serial banked sera from a child cohort at high risk, modeling whether the breadth, magnitude and durability of specific antibody responses track with intestinal barrier function and growth.
  4. Determine how resident gut bacteria protect against persistent Giardia infection by transferring microbiota between well-nourished and susceptible mice, testing whether bacterial bile acid metabolism confers protection and whether microbes are required for effective immunity.
  5. Dissect how Giardia infection and dietary protein deficiency together cause intestinal barrier dysfunction and growth restriction, using gnotobiotic mice with metagenomics and metabolomics to track aromatic amino acid metabolites, bile acids and shifts toward pathogenic bacterial functions.

More about the research

Work in this lab asks how a parasite that often seems silent damages the gut lining and stunts growth, approaching the question from two directions: the molecules Giardia releases into the intestine, and the diet-dependent community of resident gut bacteria that determines whether a child can resist the infection in the first place.

Why it matters

Giardia infection is near-universal among children in low- and middle-income settings and contributes to stunted growth even when it causes no symptoms. Identifying which secreted parasite proteins drive gut injury, and which antibody responses let children keep growing despite infection, could point to an anti-pathology vaccine or antibody therapy. Showing how dietary protein and gut bacteria, including bile acid metabolism, govern susceptibility could support microbial or nutritional treatments for impaired gut function in malnourished children.

Known grants

From NIH and NSF research grants. Labs often have other funding we can't see.

Targeting the Giardia secretome to reduce growth impairment

NIH · May 2026 – Apr 2031

Interactions of dietary protein intake and intestinal resident microbiota affecting susceptibility to persistent Giardia infection and Giardia mediated enteropathy

NIH · Sep 2020 – Aug 2026

Closest labs

Carol Gilchrist

University of Virginia, VA·Microbiology & Immunology

Optimize the systemic and mucosal immune responses raised by prototype vaccines based on the Cryptosporidium antigens Cp17, Cp23, and CpSMP delivered in liposomes with toll-like receptor agonists, immune-alarm triggers that boost antibody and cellular responses.

Carrie Cowardin

University of Virginia, VA·Microbiology & Immunology

Test whether gut microbiota from stunted human infants drive dysregulated intestinal immunity, using germ-free mice colonized with stunted or healthy infant microbiota whose pups are weaned onto a nutrient-deficient diet.

Jenessa Winston

Ohio State University, OH·Microbiology & Immunology·Early-career

Test whether daily supplementation with the secondary bile acid ursodeoxycholic acid (UDCA) changes susceptibility to and severity of Clostridioides difficile infection in IL10-knockout colitis mice.

The school

University of North Carolina at Chapel Hill: 72 labs on PI Pages, $1.6B a year on research, 523 research doctorates a year.

More about University of North Carolina at Chapel Hill

Reach out

A start for your email. Fill in the brackets.